Calliditas announces positive TRANSFORM Phase 2b topline data in primary biliary cholangitis ...Middle East

PR Newswire - News
STOCKHOLM, July 26, 2024 /PRNewswire/ -- Calliditas Therapeutics AB (NASDAQ: CALT) (STOCKHOLM: CALTX) ("Calliditas") today announced that the Phase 2b TRANSFORM trial met its primary endpoint, showing statistically significant improvement in ALP (Alkaline Phosphatase) for both doses...

Hence then, the article about calliditas announces positive transform phase 2b topline data in primary biliary cholangitis was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Calliditas announces positive TRANSFORM Phase 2b topline data in primary biliary cholangitis )

Apple Storegoogle play

Last updated :

Also on site :